Induction of chronic non-inflammatory widespread pain increases cardiac sympathetic modulation in rats by Oliveira, Larissa Resende et al.
  Universidade de São Paulo
 
2012
 
Induction of chronic non-inflammatory
widespread pain increases cardiac
sympathetic modulation in rats
 
 
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, AMSTERDAM, v. 167, n.1-2, pp. 45-49, APR
3, 2012
http://www.producao.usp.br/handle/BDPI/42419
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Outros departamentos - FMRP/Outros Artigos e Materiais de Revistas Científicas - FMRP/Outros
Induction of chronic non-inﬂammatory widespread pain increases cardiac
sympathetic modulation in rats
Larissa Resende Oliveira a, Vitor Ulisses de Melo a, Fabricio Nunes Macedo a, Andre Sales Barreto a,
Daniel Badaue-Passos Jr. a, Marcio Roberto Viana dos Santos a, Daniel Penteado Martins Dias d,
Kathleen A. Sluka b, Josimari M. DeSantana c, Valter J. Santana-Filho c,⁎
a Department of Physiology, Federal University of Sergipe, São Cristovão, Brazil
b Graduate Program in Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA, United States
c Department of Physical Therapy, Federal University of Sergipe, Aracaju, Brazil
d Department of Physiology, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
a b s t r a c ta r t i c l e i n f o
Article history:
Received 13 October 2011
Received in revised form 8 December 2011
Accepted 9 December 2011
Keywords:
Fibromyalgia
Chronic muscle pain
Blood pressure
Cardiovascular variability
Baroreﬂex
Sequence method
Fibromyalgia (FM) is characterized by chronic non-inﬂammatory widespread pain (CWP) and changes in
sympathetic function. In attempt to elucidate the pathophysiological mechanisms of FM we used a well-
established CWP animal model. We aimed to evaluate changes in cardiac autonomic balance and baroreﬂex
function in response to CWP induction in rats. CWP was induced by two injections of acidic saline (pH 4.0,
n=8) ﬁve days apart into the left gastrocnemius muscle. Control animals were injected twice with normal
saline (pH 7.2, n=6). One day after the second injection of acidic saline or normal saline, the animals had
pulse interval (PI) and systolic arterial pressure (SAP) variability, and spontaneous baroreﬂex sensitivity
(BRS) evaluated. After induction of CWP, there was an increase of power in the low frequency (LF) band of
PI spectrum (12.75±1.04 nu), a decrease in the high frequency (HF) band (87.25±1.04 nu) and an increase
of LF/HF ratio (0.16±0.01), when compared to control animals (7.83±1.13 nu LF; 92.16±1.13 nu HF;
0.08±0.01 LF/HF). In addition, there was an increase of power in the LF band of SAP spectrum
(7.93±1.39 mmHg2) when compared to control animals (2.97±0.61 mmHg2). BRS was lower in acidic
saline injected rats (0.59±0.06 ms/mmHg) when compared to control animals (0.71±0.03 ms/mmHg).
Our results showed that induction of CWP in rats shifts cardiac sympathovagal balance towards sympathetic
predominance and decreases BRS. These data corroborate ﬁndings in humans with FM.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Chronic pain is characterized by an abnormal and non-protective
response to a stimulus with duration of more than six months or that
outlasts normal tissue healing time (DeSantana and Sluka, 2008). Epi-
demiological studies show that nearly 14% of the North American pop-
ulation suffers with chronic pain (Clauw and Crofford, 2003), and
ﬁbromyalgia alone affects six million of the North American population
(2–7% of thewhole population) (Wolfe et al., 1990; Clauw and Crofford,
2003).
Fibromyalgia syndrome is characterized by widespread pain,
hypersensitivity, stiffness, sleep disorder and pronounced fatigue
(Boissevain andMcCain, 1991). The underlying mechanisms for ﬁbro-
myalgia are virtually unknown. However, several mechanisms have
been proposed such as ischemia/muscular dysfunction (Bengtsson
and Henriksson, 1989; Henriksson and Bengtosson, 1991), central
sensitization (Price et al., 2002; Clauw and Crofford, 2003; Staud
et al., 2005) or disturbances on endogenous modulatory pain systems
(Kosek et al., 1996; Julien et al., 2005). The bulk of the literature sup-
ports a disturbance in central pain modulation. To better understand
the mechanisms underlying chronic widespread pain, an animal
model was developed that involves two intramuscular injections of
acidic saline (AS pH 4.0). This model produces long-lasting diffuse
mechanical hyperalgesia without motor disturbances or signiﬁcant
tissue damage. The hyperalgesia produced in this model is dependent
on the pH and the time (days) between AS administration (Sluka
et al., 2001). The hyperalgesia occurs in muscle, skin and viscera
(Sluka et al., 2001; Miranda et al., 2004; Yokoyama et al., 2007).
This model shows enhanced excitability in the central nervous sys-
tem. Speciﬁcally, there is also an increase in the excitability in spinal
neurons characterized by a bilateral increase of the receptive ﬁeld,
phosphorylation of cAMP response element-binding (CREB) tran-
scription factor (Sluka et al., 2003; Hoeger-Bement and Sluka,
2003), and an increase in release of glutamate in spinal cord and
brainstem (Skyba et al., 2005; Radhakrishnan and Sluka, 2009).
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Further the hyperalgesia is prevented and reversed by blockade of
neuronal activity in the spinal cord and brainstem (Skyba et al.,
2002; Tillu et al., 2008; Da Silva et al., 2010a). In addition, this model
is sensitive to pharmacological and non-pharmacological treatments
(exercise) similar to that observed in people with ﬁbromyalgia
(Sluka et al., 2002; Nielsen et al., 2004; Yokoyama et al., 2007).
Thus, this model is a useful tool to understand the underlying mech-
anisms of chronic widespread pain with a strong component of
central sensitization, like ﬁbromyalgia.
Subjects with ﬁbromyalgia have a higher cardiovascular risk asso-
ciated with changes in cardiac sympathetic modulation (Figueroa
et al., 2008). Further, people with ﬁbromyalgia subjected to tilt
maneuvers show postural orthostatic tachycardia syndrome (Staud,
2008a), suggesting autonomic nervous system dysfunction. The
brainstem site involved in this model, the rostral ventromedial me-
dulla, in addition to mediating nociception, also plays a role in modu-
lating cardiovascular and autonomic responses (Machado et al.,
2000). Therefore, the present study aimed to evaluate the cardiac au-
tonomic modulation in rats after induction of non-inﬂammatory
chronic widespread pain, in an attempt to elucidate the mechanisms
involved in the pathophysiology of ﬁbromyalgia. Furthermore, the
understanding of the cardiac autonomic modulation in this model
could help develop appropriate treatment for ﬁbromyalgia, decreas-
ing the cardiovascular risk of this disease.
2. Methods
The experimental protocols performed in the current study were
in accordance with the Guidelines for Ethical Care of Experimental
Animals and were approved by the Animal Research Ethics Commit-
tee of the Federal University of Sergipe (Aracaju, SE, Brazil; Protocol
#001/2010). Research trials were conducted on male Wistar rats
weighing 250–300 g, obtained from the animal care facility of the
Federal University of Sergipe. Rats were individually housed with
unrestricted access to food and tap water and were maintained at
an ambient temperature of 22±1 °C, on a 12 h light–dark cycle. For
the study, the animals were allocated in two groups: acidic saline
group (pH 4.0; n=8) and normal saline group (pH 7.2; n=6).
2.1. Measurement of mechanical sensitivity
Rats were tested for response to mechanical stimulation with von
Frey ﬁlaments. Animals were placed in clear cubicles on an elevated
glass plate and allowed to acclimate to the new environment for at
least 30 min before testing. Von Frey ﬁlaments of varying bending
forces (14.7 to 240.1 mN) were applied to the plantar surface of the
posterior paw until the animal withdrew its paw (Gopalkrishnan
and Sluka, 2000). The lowest force at which the animal withdrew
the paw on one of the two applications was recorded as paw with-
drawal threshold. A decrease in withdrawal thresholds was inter-
preted as secondary mechanical hyperalgesia. We have previously
established the test–retest reliability of this method (Sluka et al.,
1999).
2.2. Induction of chronic muscle pain
Before the ﬁrst injection of acidic or normal saline into the gas-
trocnemius muscle, the animals had their paw withdrawal threshold
evaluated in order to record the baseline value. Immediately after
establishing the paw withdrawal threshold, animals of both groups
were anesthetized with isoﬂurane (2–5%) and injected with acidic
saline (100 μL of sterile saline at pH 4.0) or normal saline (100 μL of
sterile saline at pH 7.2) in the left gastrocnemius muscle. This proce-
dure was performed again 5 days after the ﬁrst injection. This proce-
dure produces bilateral mechanical hyperalgesia lasting for 4 weeks
after the second injection (Sluka et al., 2001).
2.3. Measurement of cardiovascular responses
One day after the second injection of acidic or normal saline into
the gastrocnemius muscle, animals were anesthetized with thiopen-
tal sodium (50 mg/kg, i.p.) and were implanted with a polyethylene
catheter (PE-10/PE-50, Intramedic, Becton Dickinson and Company,
Sparks, MD, USA) into the femoral artery. The catheter was tunneled
to the back of the rats and exteriorized on the back neck in the nape,
and surgical incision sites were closed by sutures.
Twenty-four hours later, the arterial catheter was connected to a
pressure transducer (Edwards Lifescience, Irvine, CA, USA) coupled
to a preampliﬁer (BioData, Model BD-01, PB, Brazil). Pulsatile arterial
pressure (BP) was recorded for 30 min using an IBM/PC equipped
with an analog-to-digital interface (2 kHz; BioData, BD, Brazil). The
pulsatile arterial pressure recordings were processed using a comput-
er software (Advanced CODAS/Windaq, Dataq Instruments Inc.,
Akron, OH, USA) that identiﬁes inﬂection points on signals and gener-
ates beat-by-beat time series with systolic arterial pressure (SAP),
diastolic arterial pressure (DAP), mean arterial pressure (MAP),
heart rate (HR) and pulse interval (PI) values.
2.4. Data analysis
The PI and SAP variability analysis was performed using a custom
computer software program (CardioSeries v1.2 – http://sites.google.
com/site/cardioseries). Beat-by-beat series obtained from pulsatile
arterial pressure recordings were converted to data points every
100 ms using cubic spline interpolation (10 Hz). The interpolated se-
ries was divided into half-overlapping sequential sets of 512 data
points (51.2 s). Before calculation of the spectral power density, seg-
ments were visually inspected and nonstationary data were not taken
into consideration. A Hanning window was used to attenuate side
effects and the spectrum was computed using a direct FFT algorithm
for discrete time series. The spectra were integrated in the low fre-
quency band (LF; 0.2–0.75 Hz) and the high frequency band (HF;
0.75–3 Hz), and results are presented in absolute and normalized
form, by dividing LF and HF power by the total power minus very
low frequency (VLF; b0.2 Hz) power.
The baroreﬂex sensitivity (BRS) was assessed in the time-domain
by means of the Sequence technique, as described by Di Rienzo et al.
(1985). A custom computer software (Analyzer v4.4 – http://www.
haraldstauss.com) scanned beat-by-beat time series of SAP and PI
searching for sequences of at least 4 consecutive beats in which in-
creases in SAP were followed by PI lengthening (up sequence) and
decreases in SAP were followed by PI shortening (down sequence),
with a linear correlation higher than 0.85. The slope of the linear re-
gression lines between SPB and PI was taken as a measure of BRS.
2.5. Statistical analysis
In order to evaluate the cardiac autonomic modulation in rats after
induction of non-inﬂammatory chronic widespread pain, paired and
unpaired t-tests were carried out to analyze data. Differences were
considered statistically signiﬁcant if pb0.05. The results are
presented as mean±standard error of mean (SEM).
3. Results
Table 1 shows data of paw withdrawal threshold on day 0, before
the ﬁrst intramuscular injection of normal saline (NSG; n=6) or acid-
ic saline (ASG; n=8), as well as on day 6 (24 h after the second injec-
tion) in both groups. There was a signiﬁcant decrease in paw
withdrawal threshold, bilaterally, in the ASG rats as previously
shown (Sluka et al., 2001) and thus establishes the development of
enhanced mechanical sensitivity.
46 L.R. Oliveira et al. / Autonomic Neuroscience: Basic and Clinical 167 (2012) 45–49
We next determined if there were differences in cardiovascular
responses after the development of mechanical hypersensitivity. In
the group injected with acidic saline there was an increase in the
basal HR (p=0.01) (Table 1). However, the MAPwas similar between
the group injected with acidic saline and the group injected with nor-
mal saline (p=0.4) (Table 1). In the group injected with acidic saline,
there was greater power in the LF band of PI spectrum (12.75±1.04
vs. 7.83±1.13 nu ) and smaller power in the HF band of the PI spec-
trum (87.25±1.04 vs. 92.16±1.13 nu) when compared to the group
injected with normal saline. This resulted in a greater LF/HF ratio
(0.16±0.01 vs. 0.08±0.01; Fig. 1), an indication of enhanced
sympathetic activation. To further determine alterations in sympa-
thetic activity, we analyzed the LF and HF bands of the SAP spectrum.
The group injected with acidic saline showed greater power in LF
band of SAP spectrum (7.93±1.39 vs. 2.97±0.61 mmHg2; Fig. 1),
further supported enhanced sympathetic activation. Lastly, we exam-
ined the baroreceptor reﬂex sensitivity to determine the differences
in cardiac baroreﬂex function after the development of mechanical
hypersensitivity.
In the group injected with acidic saline, there was a lower BRS
when compared to the group injected with normal saline (0.59±0.06
vs. 0.71±0.03 ms/mmHg; Fig. 1).
Table 1
Mean values of paw withdrawal threshold on day 0 (ﬁrst injection) and day 6 (after second injection), mean arterial pressure (MAP) and heart rate (HR) in rats injected with acidic
saline or neutral saline into the gastrocnemius muscle.
Right pawwithdrawal threshold (mN) Left paw withdrawal threshold (mN) MAP
(mmHg)
HR (bpm)
Day 0 Day 6 Day 0 Day 6
Acidic saline group 92±22.40 28±4.04⁎ 132±26.90 27±1.82⁎ 131±2.22 409±11.64†
Neutral saline group 108±31.19 113±20.83 105±16.96 105±16.93 134±4.05 355±11.93
*pb0.05 compared to Day 0 in the same paw. † pb0.05 compared to Neutral saline group.
Fig. 1. Power of PI spectra at low frequency band (LF; panel A), high frequency band (HF; panel B) and LF/HF ratio (panel C), power of SAP spectra at LF (panel D) and baroreﬂex
sensitivity (BRS; panel E) of rats injected with acidic saline and neutral saline into the gastrocnemius muscle. * pb0.05 compared to acidic saline.
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4. Discussion
The current study shows, for the ﬁrst time, that induction of
chronic muscle pain in rats results in modulation of the cardiac auto-
nomic system. Speciﬁcally, we show that after development of me-
chanical hypersensitivity, induced by two intramuscular injections
of acidic saline (pH 4.0), shifts the cardiac autonomic balance towards
a sympathetic predominance and reduction in baroreceptor reﬂex
sensitivity.
Supporting our ﬁndings, previous studies in humans show a rela-
tionship between cardiovascular disorders (e.g. dysautonomia) and
ﬁbromyalgia (FM) (Martínez-Lavín et al., 1997; Staud, 2008a;
Solano et al., 2009; Reyes Del Paso et al., 2010). This cardiac autonom-
ic dysfunction (i.e. dysautonomia) may be accompanied by sympa-
thetic hyperactivity at rest and sudden sympathetic changes during
orthostatic tests (i.e. increase in HR and decrease in heart rate vari-
ability and BRS) (Cohen et al., 2001; Friederich et al., 2005; Furlan
et al., 2005). The literature shows that chronic muscle pain pathogen-
ic mechanism is closely associated with sympathetic modulation
dysfunction and baroreﬂex dysfunction (Cohen et al., 2000; Raj et al.,
2000; Martínez-Lavin, 2004; Figueroa et al., 2008). These ﬁndings are
symptoms of ﬁbromyalgia (Clauw and Crofford, 2003) and other syn-
dromes also characterized by chronic pain, such as chronic fatigue
syndrome (Tak et al., 2009). Thus, the current study is the ﬁrst to doc-
ument a relationship between cardiac autonomic dysfunction and
chronic widespread pain in rats that mimics that found in people
with chronic widespread pain (Staud, 2008b; Di Franco et al., 2009).
Chronic widespread pain induced in this animal model by repeat-
ed injections of acidic saline is initiated by activation of acid-sensing
ion channels in muscle (Sluka et al., 2003) but once developed is
maintained by changes in the central nervous system (Sluka et al.,
2001, 2003; Skyba et al., 2005;). While changes in excitability occur
in the spinal cord as measured by neuronal hyperexcitability, in-
creased glutamate release, and phospohorylation of transcription fac-
tors (Skyba et al., 2002, 2005; Radhakrishnan and Sluka, 2009),
supraspinal sites likely mediate the widespread nature of the
hyperalgesia.
The rostral ventromedial medulla (RVM) is a brain site involved in
pain modulation and can both inhibit and facilitate nociceptive re-
sponses. In the acidic saline model, blockade of neuronal activity
with a local anesthetic during the second injection of acidic saline
prevents the development of hyperalgesia 24 h later; and reverses
the mechanical hypersensitivity once developed (Tillu et al., 2008),
suggesting an enhanced facilitation. The RVM is not only involved in
nociception but also in autonomic responses, and thus has multiple
effector functions (Foo and Mason, 2005; Mason, 2005). The RVM
projects to the spinal cord where it targets the dorsal horn and sym-
pathetic preganglionic neurons (Allen and Cechetto, 1994; Mason,
2005). With respect to sympathetic control, inhibition of the RVM
reduces the tachycardia evoked by air-jet stress, and autonomic
responses in fear conditioning (Zaretsky et al., 2003; Vianna et al.,
2008).
Glutamate in the RVM plays a critical role in the development and
maintenance of the hypersensitivity in this model of acidic saline
(Radhakrishnan and Sluka, 2009; Da Silva et al., 2010a). Glutamate
in the RVM can also modulate the cardiac autonomic system
(de Toledo Bergamaschi et al., 2006). In response to the second acidic
saline injection there is an increase in glutamate release in the RVM
and blockade of NMDA glutamate receptors (N-methyl-D-aspartate)
in the RVM reversed the mechanical hyperalgesia (Radhakrishnan
and Sluka, 2009; Da Silva et al., 2010b). With respect to autonomic re-
sponses, injection of glutamate into the RVM increases MAP and HR
(Bazil and Gordon, 1991; Zaretsky et al., 2003) and glutamate recep-
tors mediate sympathoexcitatory responses in rostral ventrolateral
medulla (RLVM) (Bardgett et al., 2010) showing their role in mediat-
ing pain facilitation and autonomic nervous system control. These
ﬁndings show interplay between central pathways, namely the
RVM, for both chronic widespread muscle pain and cardiac autonom-
ic modulation. The increases in glutamate and activation of NMDA re-
ceptors in the RVM, could explain or result in long term development
of permanent and potentially lethal cardiovascular disturbances in
people with ﬁbromyalgia.
5. Conclusions
There are studies in the literature showing that cardiac autonomic
dysfunction may be used to diagnose ﬁbromyalgia. To our knowledge,
this is the ﬁrst study to demonstrate the presence of autonomic car-
diovascular dysfunction in an animal model of chronic widespread
muscle pain, showed by changes in baroreﬂex control and cardiac au-
tonomic modulation. Additional studies are needed to better under-
stand the relationship between cardiac autonomic control and
ﬁbromyalgia pathophysiology.
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